Pulmonary: What It Is and Why It Matters

Pulmonary medicine sits at the intersection of chronic disease management, critical illness, and environmental health — encompassing the diagnosis, treatment, and prevention of conditions affecting the lungs and respiratory tract. This page provides a reference-grade overview of what the pulmonary field includes, how it is classified, where regulatory and safety frameworks apply, and how the specialty boundaries are drawn. The site's library spans more than 60 in-depth articles covering conditions, diagnostics, treatments, clinical careers, and patient management topics across the full respiratory spectrum.

Why This Matters Operationally

Chronic lower respiratory diseases rank as the 4th leading cause of death in the United States, according to the Centers for Disease Control and Prevention (CDC). Lung cancer remains the leading cause of cancer death for both men and women in the US. Approximately 16 million Americans carry a diagnosed COPD diagnosis, while the CDC estimates an equivalent number remain undiagnosed. Pulmonary embolism causes an estimated 100,000 deaths per year in the US (CDC). These are not incidental figures — they define the disease burden that pulmonary medicine is structurally designed to address.

Beyond mortality, respiratory conditions drive enormous healthcare utilization. Asthma alone accounts for roughly 1.6 million emergency department visits annually in the US (CDC Asthma Surveillance Data). Pulmonary hypertension, once considered uniformly fatal within 3 years of diagnosis, now has an expanding pharmacologic pipeline under active FDA oversight. Sleep apnea affects an estimated 30 million Americans, with reimbursement, device regulation, and diagnostic criteria all subject to federal agency review.

The operational stakes are compounded by environmental exposure law, occupational safety standards, and insurance coding requirements — all of which impose specific documentation obligations on pulmonary practitioners and hospitals. For a structured breakdown of the statutory and regulatory environment, see Regulatory Context for Pulmonary.

What the System Includes

Pulmonary medicine — also framed as pulmonology — is the medical subspecialty focused on diseases and disorders of the respiratory system. A full definition of the specialty's scope is covered at What Is Pulmonology.

The respiratory system, as defined by anatomical convention, includes:

Pulmonary medicine's primary focus is the lower respiratory tract and the gas exchange apparatus. The upper airway is shared territory with otolaryngology (ENT). The pleural space is shared with thoracic surgery. The pulmonary vasculature overlaps with cardiology. These overlaps are structural — not accidental — and they generate the specialty boundary questions addressed in Pulmonology vs Thoracic Surgery: Understanding the Difference.

The full anatomy and physiological function of the respiratory system — including ventilation mechanics, diffusion gradients, and perfusion matching — form the foundational science that every pulmonary diagnosis references.

Core Moving Parts

Pulmonary medicine operates through three functional domains: diagnostic evaluation, disease management, and procedural intervention.

Diagnostic evaluation relies on a defined toolkit:

Modality Primary Information Named Standard
Pulmonary Function Tests (PFTs) Airflow obstruction, restriction, diffusion capacity ATS/ERS standardization guidelines
Chest X-Ray Structural abnormality, infiltrates, effusion ACR Appropriateness Criteria
CT Scan (Chest) Nodule characterization, parenchymal detail Lung-RADS (ACR)
Arterial Blood Gas (ABG) Acid-base status, oxygenation, ventilation AARC Clinical Practice Guidelines
Bronchoscopy Airway visualization, tissue sampling ACCP guidelines
Sleep Studies Sleep-disordered breathing severity AASM scoring rules

Disease management spans pharmacologic therapy (inhaler therapy, biologics, anticoagulation), behavioral intervention (smoking cessation, pulmonary rehabilitation), and device-based treatment (oxygen therapy, CPAP/BiPAP).

Procedural intervention ranges from bronchoscopic procedures to thoracentesis to lung transplant coordination — though the latter bridges into thoracic surgery's domain.

Where the Public Gets Confused

Several persistent misconceptions distort public understanding of pulmonary medicine.

Misconception 1: Pulmonology and cardiology are separate silos. The lung and heart share a circulatory circuit. Pulmonary hypertension is classified into 5 groups by the World Health Organization (WHO), and Groups 2 and 3 are directly caused by left heart disease and lung disease respectively. Shortness of breath frequently requires joint cardiopulmonary evaluation. The two specialties overlap substantially in the ICU and in heart-lung transplant programs.

Misconception 2: Asthma and COPD are the same disease. Both involve airflow obstruction, but the mechanisms differ fundamentally. Asthma involves reversible bronchoconstriction driven by airway hyperresponsiveness. COPD involves largely irreversible airflow limitation from emphysema and chronic bronchitis, predominantly caused by long-term smoke or particulate exposure. GOLD (Global Initiative for Chronic Obstructive Lung Disease) and GINA (Global Initiative for Asthma) maintain entirely separate evidence-based guidelines for each condition.

Misconception 3: Pulse oximetry is equivalent to an ABG. Pulse oximetry measures peripheral oxygen saturation (SpO₂) — a single variable. An arterial blood gas measures PaO₂, PaCO₂, pH, bicarbonate, and base excess simultaneously. A patient with hypercapnic respiratory failure may display a normal SpO₂ reading while retaining dangerous levels of CO₂.

Misconception 4: Pulmonary fibrosis is just "scarring" with no treatment. Pulmonary fibrosis — specifically idiopathic pulmonary fibrosis (IPF) — has 2 FDA-approved antifibrotic agents (pirfenidone and nintedanib) that demonstrably slow disease progression based on phase III trial data. The ATS/ERS/JRS/ALAT 2022 guidelines address their use explicitly.

Boundaries and Exclusions

Pulmonary medicine has defined boundaries that are clinically and administratively important.

What pulmonology covers:
- Obstructive lung diseases (asthma, COPD, bronchiectasis)
- Interstitial lung diseases (pulmonary fibrosis, hypersensitivity pneumonitis, sarcoidosis)
- Pulmonary vascular diseases (pulmonary embolism, pulmonary hypertension)
- Pleural diseases (pleural effusion, pneumothorax)
- Respiratory infections (pneumonia, tuberculosis)
- Sleep-disordered breathing (sleep apnea)
- Lung cancer screening and management coordination (lung cancer screening)
- Occupational lung disease
- Ventilator management in the ICU (via the critical care subspecialty)

What pulmonology does not cover (typical boundary):
- Surgical resection of lung masses — this falls to thoracic surgery
- Cardiac arrhythmias causing dyspnea — cardiology
- Nasopharyngeal or laryngeal cancers — ENT/head and neck oncology
- Neuromuscular causes of respiratory failure in isolation — neurology

The subspecialties within pulmonary medicine — critical care, interventional pulmonology, sleep medicine, and pediatric pulmonology — each carry further boundary definitions. These are mapped in detail at Subspecialties of Pulmonary Medicine.

The Regulatory Footprint

Pulmonary medicine operates within a layered regulatory environment.

Federal agencies with direct oversight:

Billing, coding, and documentation standards for pulmonary procedures are governed by CPT codes maintained by the American Medical Association and applied through CMS fee schedules. A structured review of this landscape is available at Regulatory Context for Pulmonary.

For answers to common procedure- and coverage-related questions, Pulmonary: Frequently Asked Questions addresses the most common points of confusion in plain reference format.

What Qualifies and What Does Not

The following framework reflects standard classification criteria used in clinical practice:

Conditions that qualify as pulmonary diagnoses (ICD-10 J-code range predominantly):
- Obstructive: J44 (COPD), J45 (asthma), J47 (bronchiectasis)
- Interstitial: J84 (interstitial lung disease cluster)
- Vascular: I27 (pulmonary hypertension), I26 (pulmonary embolism — coded under circulatory)
- Infectious: J18 (pneumonia), A15–A16 (tuberculosis)
- Pleural: J90 (pleural effusion), J93 (pneumothorax)
- Sleep-related: G47.3 (sleep apnea)

Procedures requiring pulmonary specialist credentialing (per hospital privileging standards and ACCP competency frameworks):
- Flexible bronchoscopy with bronchoalveolar lavage
- Endobronchial ultrasound (EBUS)
- Medical thoracoscopy
- Intubation and mechanical ventilator management
- Polysomnography interpretation

Procedures that do not require pulmonary credentialing in most hospital systems:
- Routine spirometry (may be performed by trained respiratory therapists under supervision)
- Pulse oximetry monitoring
- Nebulizer therapy administration

The history of how these classifications and credentialing standards developed is traced in History of Pulmonary Medicine as a Specialty. Information on the day-to-day scope of the specialist's role is covered in What Does a Pulmonologist Do.

Primary Applications and Contexts

Pulmonary medicine applies across four primary institutional contexts:

1. Outpatient clinic: Management of stable chronic conditions — COPD exacerbation prevention, asthma controller therapy titration, IPF monitoring, sleep apnea follow-up, post-COVID respiratory sequelae. The majority of pulmonary patient encounters occur in this setting.

2. Inpatient hospital: Acute pneumonia, acute exacerbations of COPD, pulmonary embolism with hemodynamic compromise, pleural effusion drainage, respiratory failure requiring mechanical ventilation. CMS data show respiratory conditions among the top 5 principal diagnoses for adult inpatient stays.

3. Intensive care unit (ICU): The critical care subspecialty of pulmonary medicine provides direct management of mechanically ventilated patients, ARDS (Acute Respiratory Distress Syndrome), and multi-organ failure involving respiratory compromise. The Berlin Definition (2012) formally classified ARDS severity into mild (PaO₂/FiO₂ 200–300), moderate (100–200), and severe (<100) categories.

4. Occupational and environmental medicine interface: Pulmonary evaluation of workers exposed to silica, asbestos, coal dust, isocyanates, and beryllium follows structured surveillance protocols. NIOSH-certified B readers perform pneumoconiosis classification using ILO standards. Occupational lung disease remains a distinct clinical and medicolegal domain within the specialty.

The Authority Network America at authoritynetworkamerica.com provides the broader publishing infrastructure within which this pulmonary reference property operates, alongside parallel authority sites across medical and health verticals.

Across all four contexts, the reference point for understanding what pulmonary medicine is — its instruments, its limits, its regulatory environment, and its clinical logic — is the respiratory system itself. Every diagnostic test, treatment protocol, and billing classification traces back to the anatomy and physiology of gas exchange, airway mechanics, and vascular physiology that define the field's functional domain.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)